Tests a resilience program for young people with sickle cell disease
Tests a stress-management program for young people living with sickle cell disease.
Key facts
- Who runs it
- Boston Children's Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
- Status
- Recruiting
- People taking part
- 25 people, planned
- Started
- 23 Oct 2025
- Expected to end
- Sept 2030
- Type of study
- Interventional
- Treatments tested
- Collaborative Care Model
- Promoting Resilience in Stress Management
- Record updated
- 5 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children, teens and young adults with sickle cell disease who have some signs of depression or anxiety. It tests a program that builds resilience.
- Age
- 8 to 25 years
- Sex
- All sexes can join.
- Disease stage
- Sickle cell disease (HbSS, HbSC, HbS-Beta Thalassemia, and other related hemoglobinopathies).
- Earlier treatment
- Must be receiving medical care at the DFCI/BCH Blood Disorders Center.
- Biomarker or test result
- A score above 9 on the PHQ-9 questionnaire or on the GAD anxiety questionnaire.
Main reasons for not taking part
- Cannot speak English or Spanish
- Cannot read English or Spanish
- Cannot take part in the sessions or complete the questionnaires because of thinking or understanding difficulties, as judged by the site investigator
- Cannot follow the study visit schedule and other requirements
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Aged ≥ 8 and ≤ 25 years of age at baseline
- Diagnosed with Sickle Cell Disease (HbSS, HbSC, HbS-Beta Thalassemia, and other related hemoglobinopathies)
- Receiving Medical Care at the DFCI/BCH Blood Disorders Center
- Scored > 9 on Patient Health Questionnaire 9-item (PHQ-9) or Generalized Anxiety Disorder (GAD)
- Able to speak English or Spanish language (for PRISM sessions)
- Able to read English or Spanish language (for completion of surveys)
- Cognitively able to participate in PRISM sessions and complete written questionnaires and surveys, as judged by the site investigator
- Willing and able to adhere to the study visit schedule and other protocol requirements
Who cannot take part
- does not meet above criteria
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 25 years old?
Where in United States
- Boston Children's HospitalBoston, United StatesContact: Abby Rosenberg, MDTaking people
About the trial
What the trial wants to find out
Adolescents and young adults with sickle cell disease (SCD) face challenges managing their illness and maintaining their well-being. This study proposes to test the feasibility and acceptability of a resilience-promoting intervention through a Collaborative Care Model. The primary goal is to determine with the resilience intervention (PRISM) is feasible and acceptable for adolescents and young adults with SCD. Exploratory outcomes include whether this intervention improves depression, anxiety, and pain interference.
The group in the trial
- CoCM+PRISMTreatment being tested
Collaborative Care Model (CoCM) includes a care manager, a defined population of patents/registry for tracking inclusion and progress, validated patient-reported outcome measures, and weekly inter-professional team meetings. This arm includes the use of an inter professional team to triage, plan and deliver care. the PRISM intervention, a brief, skills-based program targeting 4 resilience resources, will be delivered 1:1 as part of this treatment arm.
Treatment: Collaborative Care Model and Promoting Resilience in Stress Management
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
- Plain-language title
- Tests a resilience program for young people with sickle cell diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06555939, who can take part
- Record updated
- 5 May 2026